title: Autoimmune hepatitis following treatment with infliximab for inflammatory bowel disease.
authors.forename: Chiara
authors.initials: C
authors.lastname: van Casteren-Messidoro
authors.forename: Gerrie
authors.initials: G
authors.lastname: Prins
authors.forename: Antonie
authors.initials: A
authors.lastname: van Tilburg
authors.forename: Zuzana
authors.initials: Z
authors.lastname: Zelinkova
authors.forename: Joeffrey
authors.initials: J
authors.lastname: Schouten
authors.forename: Rob
authors.initials: R
authors.lastname: de Man
mesh_terms: D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003424:Crohn Disease / Q000188:drug therapy*; D019693:Hepatitis, Autoimmune / Q000209:etiology*; D006801:Humans; D008297:Male
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal